• Goldman Sachs cut its combined voting rights stake in Carl Zeiss Meditec to 5.39% from 5.58%.
• Holdings via shares rose to 0.63% from 0.57%.
• Exposure through instruments fell to 4.76% from 5.01%.
• The threshold crossing date was Aug. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2394168_en) on September 04, 2026, and is solely responsible for the information contained therein.